FEATURED COMPANIES
- Abbott Laboratories
- Alere Inc.
- bioMerieux
- Danaher Corporation
- Diazyme Laboratories
- EKF Diagnostics
POC HbA1C Testing Global Market Opportunities And Strategies To 2030 report from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global POC HbA1C Testing market.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the POC HbA1C testing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global POC HbA1C testing market report to 2030 report from the publisher answers all these questions and many more.
The report covers the following chapters
Markets Covered:
Companies Mentioned: Bio-Rad Laboratories, Inc.; Siemens Healthineers AG; Menarini Group; F. Hoffmann-La Roche Ltd.; ARKRAY Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Gain a global perspective on the development of the market.
Description:
Where is the largest and fastest growing market for the POC HbA1C testing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global POC HbA1C testing market report to 2030 report from the publisher answers all these questions and many more.
The report covers the following chapters
- Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
- Report Structure – This section gives the structure of the report and the information covered in the various sections.
- Introduction – This section gives the segmentation of the POC HbA1C testing market by geography and segmentation by product, by technology and by end-user covered in this report.
- Market Characteristics – The market characteristics section of the report defines and explains the POC HbA1C testing market. This chapter includes different devices covered in the report and basic definitions.
- Supply Chain – The supply chain section of the report defines and explains the key players in the POC HbA1C testing industry supply chain.
- Product Analysis – The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
- Customer Information – This chapter covers recent customers’ trends/preferences in the global POC HbA1C testing market.
- Trends And Strategies – This chapter describes the major trends shaping the POC HbA1C testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
- Global Market Size And Growth – This section contains the global historic (2015 – 2019) and forecast (2019 – 2023, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
- Segmentation – This section contains the market values (2015 – 2023, 2025F, 2030F) and analysis for different segments in the market.
- Regional Analysis – This section contains the historic (2015 – 2019), forecast (2019 – 2023, 2025F, 2030F) market value and growth and market share comparison by region.
- Regional Market Size and Growth – This section contains the region’s market size (2019), historic and forecast (2015 – 2023, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
- Competitive Landscape – This section covers details on the competitive landscape of the global POC HbA1C testing market, estimated market shares and company profiles of the leading players.
- Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
- Appendix – This section includes details on the NAICS codes covered, abbreviations, currencies and research inquiries used in this report.
Markets Covered:
- By Type Of Product: Consumables; Instruments
- By Technology: Turbidimetric Inhibition Immunoassay; Affinity Binding Chromatography; Ion-Exchange HPLC; Enzymatic Assay; Others
- By End-User: Physician Office/Outpatient Center; Home Care; Hospitals; Others
Companies Mentioned: Bio-Rad Laboratories, Inc.; Siemens Healthineers AG; Menarini Group; F. Hoffmann-La Roche Ltd.; ARKRAY Inc.
Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- Alere Inc.
- bioMerieux
- Danaher Corporation
- Diazyme Laboratories
- EKF Diagnostics
1. POC HbA1C Testing Market Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure8. POC HbA1C Testing Market Supply Chain Analysis And Key Participants9. POC HbA1C Testing Market Product Analysis – Product Examples39. Copyright and Disclaimer
6. Introduction
7. POC HbA1C Testing Market Characteristics
10. POC HbA1C Testing Market Customer Information
11. POC HbA1C Testing Market Trends And Strategies
12. Global POC HbA1C Testing Market Size And Growth
13. Global POC HbA1C Testing Market
14. POC HbA1C Testing Market, Regional And Country Analysis
15. Asia-Pacific POC HbA1C Testing Market
16. China POC HbA1C Testing Market
17. India POC HbA1C Testing Market
18. Japan POC HbA1C Testing Market
19. Australia POC HbA1C Testing Market
20. Indonesia POC HbA1C Testing Market
21. South Korea POC HbA1C Testing Market
22. Western Europe POC HbA1C Testing Market
23. UK POC HbA1C Testing Market
24. Germany POC HbA1C Testing Market
25. France POC HbA1C Testing Market
26. Eastern Europe POC HbA1C Testing Market
27. Russia POC HbA1C Testing Market
28. North America POC HbA1C Testing Market
29. USA POC HbA1C Testing Market
30. South America POC HbA1C Testing Market
31. Brazil POC HbA1C Testing Market
32. Middle East POC HbA1C Testing Market
33. Africa POC HbA1C Testing Market
34. Global POC HbA1C Testing Market Competitive Landscape
35. POC HbA1C Testing Market, Key Mergers And Acquisitions
36. POC HbA1C Testing Market Future Outlook and Potential Analysis
37. Global POC HbA1C Testing Market Conclusions And Recommendations
38. Appendix
Note: Product cover images may vary from those shown
LOADING...
FEATURED COMPANIES
- Abbott Laboratories
- Alere Inc.
- bioMerieux
- Danaher Corporation
- Diazyme Laboratories
- EKF Diagnostics
This report describes and evaluates the global POC HbA1C testing market. It covers two five-year periods, 2015 to 2019, termed the historic period, and 2019 through 2023, 2025F, and 2030F the forecast period.
The global POC HbA1C testing market reached a value of nearly $483.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.37% since 2015, and is expected to grow at a CAGR of 8.0% to nearly $658.6 million by 2023.
Growth in the historic period resulted from rise in diabetes prevalence, and increase in disposable income. Factors that negatively affected growth in the historic period were lack of awareness, and development of alternative blood glucose monitoring methods.
Going forward, favorable government initiatives, changing lifestyles, and rise in diabetic population will drive growth. Factors that could hinder the growth of the POC HbA1C testing market in the future include inability of testing devices to assess all blood types.
The POC HbA1C testing market is segmented by product into consumables, and instruments. The consumables market was the largest segment of the POC HbA1C testing market segmented by product, accounting for $316.31 million or 65.4% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.
The POC HbA1C testing market is segmented by technology into turbidimetric inhibition immunoassay, affinity binding chromatography, ion-exchange HPLC, enzymatic assay, and others. The turbidimetric inhibition immunoassay market was the largest segment of the POC HbA1C testing market, accounting for $222.01 million or 45.9% of the total in 2019 and affinity binding chromatography market is expected to be the fastest-growing segment going forward at a CAGR of 11.1%.
The POC HbA1C testing market is segmented by end user into physician office/outpatient center, home care, hospitals, and others. The physician office/outpatient center market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for $270.96 million or 56.0% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.
North America was the largest region in the POC HbA1C testing market, accounting for 41.5% of the global market in 2019. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest growing regions in the POC HbA1C testing market will be Eastern Europe and Asia Pacific, where growth will be at CAGRs of 12.4% and 10.4% respectively. These will be followed by Africa and Middle East, where the markets are expected to grow at CAGRs of 10.3% and 9.1% respectively.
The POC HbA1C testing market is highly concentrated, with a small number of players dominating the market. The top ten competitors in the market made up to 72.1% of the total market in 2019. Major players in the market include Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tosoh Bioscience, Danaher corporation Trinity Biotech plc, EKF Diagnostics Holdings plc, and Others.
The top opportunities in the POC HbA1C testing market segmented by product type will arise in the consumables segment which will gain $436.75 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the affinity binding chromatography segment which will gain $245.37 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment which will gain $374.28 million of global annual sales by 2023.
The POC HbA1C testing market size will gain the most in USA at $51.56 million. Market-trend-based strategies for the POC HbA1C testing market include developing and deploying technologies to capture and analyze data from the medical devices, M&A growth strategies to expand their customer base and geographic presence, online marketing strategies to expand their customer base and geographic presence. Player-adopted strategies in the POC HbA1C testing industry include expanding the diagnostics product portfolio and increase investments in R&D, expanding its business through collaborations, strengthening of its research and development network capability globally.
Diabetic patients are considered to have higher risk of suffering complications of COVID-19, therefore their usual treatment plans may change as communities and health services look to protect sufferers and follow social distancing measures and keep them home as much as possible. According to the World Health Organization (WHO), the most at-risk populations from corona virus are older people and individuals with pre-existing medical conditions such as high blood pressure, diabetes, heart disease, lung disease, and cancer. People with these conditions seem to develop more serious illness when they contract the virus. Both diabetes type 1 and 2 can increase risk of contraction. According to current Diabetes review, type 2 diabetes can increase the incidence of infectious diseases. According to other studies, Diabetes type 1 also increases risks for morbidity and mortality. In addition to that, according to the American Diabetes Association, in China, most cases occurred so far, people with diabetes had much higher rates of serious complications and death than people without diabetes. Therefore, POC HbA1C testing of diabetic patients is necessary due to COVID-19, so that they can seek to maintain and manage their condition at home, whilst limiting their potential exposure to the virus
The global POC HbA1C testing market reached a value of nearly $483.8 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.37% since 2015, and is expected to grow at a CAGR of 8.0% to nearly $658.6 million by 2023.
Growth in the historic period resulted from rise in diabetes prevalence, and increase in disposable income. Factors that negatively affected growth in the historic period were lack of awareness, and development of alternative blood glucose monitoring methods.
Going forward, favorable government initiatives, changing lifestyles, and rise in diabetic population will drive growth. Factors that could hinder the growth of the POC HbA1C testing market in the future include inability of testing devices to assess all blood types.
The POC HbA1C testing market is segmented by product into consumables, and instruments. The consumables market was the largest segment of the POC HbA1C testing market segmented by product, accounting for $316.31 million or 65.4% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.
The POC HbA1C testing market is segmented by technology into turbidimetric inhibition immunoassay, affinity binding chromatography, ion-exchange HPLC, enzymatic assay, and others. The turbidimetric inhibition immunoassay market was the largest segment of the POC HbA1C testing market, accounting for $222.01 million or 45.9% of the total in 2019 and affinity binding chromatography market is expected to be the fastest-growing segment going forward at a CAGR of 11.1%.
The POC HbA1C testing market is segmented by end user into physician office/outpatient center, home care, hospitals, and others. The physician office/outpatient center market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for $270.96 million or 56.0% of the total in 2019 and is expected to be the fastest-growing segment going forward at a CAGR of 8.4%.
North America was the largest region in the POC HbA1C testing market, accounting for 41.5% of the global market in 2019. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest growing regions in the POC HbA1C testing market will be Eastern Europe and Asia Pacific, where growth will be at CAGRs of 12.4% and 10.4% respectively. These will be followed by Africa and Middle East, where the markets are expected to grow at CAGRs of 10.3% and 9.1% respectively.
The POC HbA1C testing market is highly concentrated, with a small number of players dominating the market. The top ten competitors in the market made up to 72.1% of the total market in 2019. Major players in the market include Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Tosoh Bioscience, Danaher corporation Trinity Biotech plc, EKF Diagnostics Holdings plc, and Others.
The top opportunities in the POC HbA1C testing market segmented by product type will arise in the consumables segment which will gain $436.75 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the affinity binding chromatography segment which will gain $245.37 million of global annual sales by 2023. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment which will gain $374.28 million of global annual sales by 2023.
The POC HbA1C testing market size will gain the most in USA at $51.56 million. Market-trend-based strategies for the POC HbA1C testing market include developing and deploying technologies to capture and analyze data from the medical devices, M&A growth strategies to expand their customer base and geographic presence, online marketing strategies to expand their customer base and geographic presence. Player-adopted strategies in the POC HbA1C testing industry include expanding the diagnostics product portfolio and increase investments in R&D, expanding its business through collaborations, strengthening of its research and development network capability globally.
Diabetic patients are considered to have higher risk of suffering complications of COVID-19, therefore their usual treatment plans may change as communities and health services look to protect sufferers and follow social distancing measures and keep them home as much as possible. According to the World Health Organization (WHO), the most at-risk populations from corona virus are older people and individuals with pre-existing medical conditions such as high blood pressure, diabetes, heart disease, lung disease, and cancer. People with these conditions seem to develop more serious illness when they contract the virus. Both diabetes type 1 and 2 can increase risk of contraction. According to current Diabetes review, type 2 diabetes can increase the incidence of infectious diseases. According to other studies, Diabetes type 1 also increases risks for morbidity and mortality. In addition to that, according to the American Diabetes Association, in China, most cases occurred so far, people with diabetes had much higher rates of serious complications and death than people without diabetes. Therefore, POC HbA1C testing of diabetic patients is necessary due to COVID-19, so that they can seek to maintain and manage their condition at home, whilst limiting their potential exposure to the virus
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Aina Blood Monitoring Sysyem
- Abbott Laboratories
- Alere Inc.
- bioMerieux
- Danaher Corporation
- Diazyme Laboratories
- EKF Diagnostics
- Getein Biotech, Inc
- HemoCue
- Instrumentation Laboratory
- Nova Biomedical
- Ortho Clinical Diagn
Note: Product cover images may vary from those shown
LOADING...